{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T12:41:52Z","timestamp":1649076112463},"reference-count":20,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Chemotherapy"],"published-print":{"date-parts":[[1999,1]]},"DOI":"10.1179\/joc.1999.11.1.54","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T18:05:03Z","timestamp":1389290703000},"page":"54-60","source":"Crossref","is-referenced-by-count":6,"title":["Strategies for Cost-Containment: Once-Daily Ceftriaxone Plus Amikacin as Empiric Therapy for Febrile Granulocytopenic Children with Cancer"],"prefix":"10.1080","volume":"11","author":[{"given":"E.","family":"Castagnola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Lanino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Giacchino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Viscoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Dini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2013,7,18]]},"reference":[{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1007\/BF00417474"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(94)90412-X"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(88)90239-8"},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0891-5520(20)30758-3","volume":"5","author":"Calandra T","year":"1991","journal-title":"Infect Dis Clin North Am"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1007\/BF01646877"},{"key":"CIT0010","first-page":"445","volume":"39","author":"International Antimicrobial EORTC","year":"1995","journal-title":"Piperacillin-tazobactam plus amikacin ver-sus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. Antimicrob Agents Chemother"},{"key":"CIT0011","first-page":"1108","volume":"40","author":"International Antimicrobial EORTC","year":"1996","journal-title":"Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. Antimicrob Agents Chemother"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/161.3.381"},{"key":"CIT0015","first-page":"584","volume":"119","author":"Antimicrobial EORTC-International","year":"1993","journal-title":"Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. Ann Intern Med"},{"key":"CIT0016","first-page":"397","volume":"13","author":"Viscoli C","year":"1991","journal-title":"Ceftazidime plus amikacin versus ceftazidime plus vancomycin as empiric thera-py in febrile neutropenic children with cancer. Rev Infect Dis"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199305063281808"},{"key":"CIT0019","first-page":"37: 1696","volume":"1993","author":"Washington JA","journal-title":"Antimicrob Agents Chemother"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1159\/000227010"},{"key":"CIT0021","first-page":"410","volume":"6","author":"Davey PG","year":"1992","journal-title":"PharmacoEconomics"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1179\/joc.1996.8.5.375"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-199201010-00006"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199311000-00005"},{"key":"CIT0026","first-page":"346","volume":"16","author":"Charnas R","year":"1997","journal-title":"Once daily cef-triaxone plus amikacin vs. three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer. Pediatr Infect Dis J"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1159\/000239590"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1086\/514512"}],"container-title":["Journal of Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10256018808623883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T16:04:09Z","timestamp":1647965049000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1179\/joc.1999.11.1.54"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,7,18]]},"published-print":{"date-parts":[[1999,1]]}},"alternative-id":["10.1179\/joc.1999.11.1.54"],"URL":"https:\/\/doi.org\/10.1179\/joc.1999.11.1.54","relation":{},"ISSN":["1120-009X","1973-9478"],"issn-type":[{"value":"1120-009X","type":"print"},{"value":"1973-9478","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,1]]}}}